安捷凯在线客服
- 客服:
- 电话: 13061953619
- 微信:
An inhibitor of wild-type and mutant EGFR and HER2
BDTX-189 is an inhibitor of wild-type and mutant EGFR and HER2 (IC50s = ≤30-500 and ≤10-100 nM, respectively).1 In vivo, BDTX-189 (30 and 50 mg/kg, twice daily) reduces tumor growth in a CUTO14 non-small cell lung cancer (NSCLC) mouse xenograft model.
1.Flohr, A., Mayweg, A., Trainor, G., et al.Quinazoline derivatives as tyrosine kinase inhibitor, compositions, methods of making them and their use(2020)
动态评分
0.0